Melanoma March is just around the corner!
1 November 2017
Melanoma March is just around the corner and we’re excited to announced that this year will be bigger than ever, and a little bit different. In addition to 20 much-loved Melanoma March events across the country, we are introducing a run component to our Melbourne March. For Sydney Marchers, we are returning to Manly and adding a stand-up paddle option as well. There’s something for everyone!
We are also delighted to announce that fitness guru and melanoma survivor Shannan Ponton is once again joining us as our official 2018 Melanoma March Ambassador. Shannan is proof that melanoma can strike anyone. He says he’s one of the lucky ones, as despite undergoing two rounds of surgery and now sporting a 20cm scar, his melanoma hadn’t spread. “Melanoma doesn’t discriminate and it is vital that everyone protects themselves and their families from the sun,” Shannan said. “Melanoma March is a fun family event that not only serves as a timely reminder about the importance of sun-safety, but it also supports life-saving research. Living a sun-smart lifestyle, early detection and investing in research are crucial if Australia is to win the melanoma battle,” he said.
Shannan is urging all Australians to sign up for a Melanoma March event near them, and then spread the word with their family and friends.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?